Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Depreciation & Amortization (CF) (2016 - 2025)

Medifast's Depreciation & Amortization (CF) history spans 16 years, with the latest figure at $3.5 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 8.79% year-over-year to $3.5 million; the TTM value through Dec 2025 reached $14.2 million, up 12.08%, while the annual FY2025 figure was $14.2 million, 12.08% up from the prior year.
  • Depreciation & Amortization (CF) reached $3.5 million in Q4 2025 per MED's latest filing, roughly flat from $3.5 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $4.0 million in Q2 2025 to a low of $1.1 million in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $2.9 million, with a median of $3.1 million recorded in 2024.
  • The largest YoY upside for Depreciation & Amortization (CF) was 422.91% in 2021 against a maximum downside of 32.25% in 2021.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $3.0 million in 2021, then fell by 2.99% to $3.0 million in 2022, then rose by 13.51% to $3.4 million in 2023, then dropped by 5.01% to $3.2 million in 2024, then increased by 8.79% to $3.5 million in 2025.
  • Per Business Quant, the three most recent readings for MED's Depreciation & Amortization (CF) are $3.5 million (Q4 2025), $3.5 million (Q3 2025), and $4.0 million (Q2 2025).